Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig

NIH RePORTER · NIH · N43 · $600,000 · view on reporter.nih.gov ↗

Abstract

GlycoScientific proposes to generate antibodies specific for six inflammatory cytokines to elucidate and correlate immunological markers of tuberculosis (TB) transmission and disease development in the guinea pig. Once the antibodies are produced, the Offeror will use them to evaluate the cytokines in TB infected and non-infected guinea pigs. The production of these crucial immunological reagents will greatly enhance our understanding of basic immune responses to TB infection in naturally infected mammalian models.

Key facts

NIH application ID
10933281
Project number
75N93023C00038-0-9999-1
Recipient
GLYCOSCIENTIFIC, LLC
Principal Investigator
MARLA POPOV
Activity code
N43
Funding institute
NIH
Fiscal year
2023
Award amount
$600,000
Award type
Project period
2023-09-01 → 2025-08-31